|
Terumo received the following information: it was reported that the needle detached from the cartridge when slight pressure was applied to the safety cap.The needle fell off the cartridge and onto the floor before the safety cap could fully enclose the needle.Additional information was received on (b)(6) 2025: the reporter screwed the needle onto the barrel, pinched the patient's skin, and administered the medication as intended.After the injection, while attempting to engage the safety cap by pressing it against a bench with minimal force, the needle detached from the device and fell to the floor.The needle did not detach during administration; it detached during activation of the safety cap.There was no patient harm reported.
|
|
A1: patient identifier: requested, not provided.A2: age & date of birth: requested, not provided.A3a: sex: requested, not provided.A4: weight: requested, not provided.A5: ethnicity: requested, not provided.A6: race: requested, not provided.B3: date of event: requested, unknown.D6a: implanted date: device was not implanted.D6b: explanted date: device was not explanted.E1: phone number: unknown.E1: establishment address: unknown.E3: occupation: indivior quality record coordinator.We were unable to determine the details of the actual condition of the sample as it was not available for evaluation.The retention samples were visually inspected and confirmed to be free of any damage or molding-related defects that could lead to the complaint.There was no issued nonconformity report related to human error during the production lot.There are no nonconformities in the assembled needle lot supplied during lot production.Our molding machine and needle assembly machine run under validated parameters using an automated machine.During the collar assembly process, the hub fit is loosened from the protector before placing the needle into the collar.Before proceeding to the next process, the hub, cannula, and collar are pressed into the protector, wherein a photoelectric sensor detects if the height of the protector is correct.An initial product inspection check (ipic) is being performed during the molding process during raw material change, mold maintenance, plant shutdown, cavity closure, and mold/product type change.Any molding defects on the hub that may affect product function are part of the inspection item.We also have a visual in-process and product confirmation inspection to ensure that the hub is in good condition.Visual in-process inspection was conducted during needle assembly, sg assembly, and the boxing process.Part of the check items is the condition of the assembled product, including damaged parts that will affect the product's function.Before shipment, we have an outgoing inspection to check the overall condition of the
product.Our needles comply with iso 80369-7, wherein they pass the dimensional and functional performance requirements.The product's instructions for use (ifu) provides detailed instructions for using the sg3 safety needle device, including warnings and precautions step 1 of the instruction for use for sg3 safety needle indicates tightening of the syringe to the needle before use.The hub is manufactured in-house with validated tpc molding machines.There were no nonconformance reports issued for the supplied molded part lots.From the previous two fiscal years to the present, we have received a total of 9 adverse event out of 42 complaints.The cause of these complaints was not identified as being related to our product or the manufacturing process.Retention samples of 19g were simulated.The samples were activated using three methods: finger, thumb, and hard surface activation.The safety sheath was successfully activated on the samples; no detachment of the hub from the syringe, and no irregularities or bending of the cannula were encountered.The cannula was captured under the sheath tooth.Based on the results of our investigation, the root cause of the complaint could not be identified to be related to our product or manufacturing process.The lot history file showed no non-conformity or any related troubles that would affect the product quality.We were also unable to confirm the device failure since the actual sample was not returned for evaluation.Instead, the retention samples were simulated, wherein no irregularities or detachment of the hub from the syringe were encountered during the activation.The retention samples were visually inspected and confirmed to be free from any molding defects that could lead to the complaint.Our needles comply with iso 80369-7, wherein it passed the functional and performance requirements.We have routine inspections to check the overall condition of the products.We recommend following the instructions for use (ifu) of the sg3 safety needle, ensuring that the needle is securely tightened until resistance is felt before use.This reported event has been deemed reportable based on an internal review and reassessment performed on (b)(6)2026.It has been found that this event was initially considered not reportable; however, after internal review and reassessment this event is currently being deemed a reportable event.Terumo medical corporation (tmc) is submitting this report on behalf of terumo (philippines) corporation (manufacturer) registration no.3003902955.
|